News, musings and commentary on dietary supplements & pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though)
Monday, February 26, 2007
EPO Drug: Bad News
Drugmaker Roche said it is suspending recruitment into a trial of Cera in anemic lung cancer patients because of an "imbalance" of deaths across the four arms of the study, which was conducted outside the U.S.